Aerobic Exercise for Type 2 Diabetes
(EPC-DM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The discovery of the role of endothelial progenitor cells (EPCs) and their involvement in the cardiovascular complications of type 2 diabetes (T2DM) would quickly have a significant impact on the millions of Americans who have T2DM. This project is designed to 1) determine the mechanisms underlying EPC dysfunction in older, sedentary adults with T2DM compared those with normal glucose metabolism and impaired glucose metabolism, and 2) determine if aerobic exercise training is an efficacious therapy for EPC dysfunction in T2DM, and whether improvement in EPC number and function translates to improved endothelial function, increased capillarization, and improved glucose metabolism in T2DM.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is aerobic exercise generally safe for humans?
Aerobic exercise is generally considered safe for humans, including those with type 2 diabetes, as it can improve heart health and help control blood sugar levels. It is recommended as part of diabetes care guidelines and has been shown to be safe and beneficial when not limited by other health conditions.12345
How is aerobic exercise training unique as a treatment for type 2 diabetes?
Aerobic exercise training is unique because it focuses on improving insulin resistance and cardiovascular health through activities like walking, cycling, and swimming, which enhance the insulin-signaling pathway. Unlike some other treatments, it can be combined with resistance training to further increase muscle strength and improve quality of life.13678
What data supports the effectiveness of the treatment Aerobic Exercise Training for Type 2 Diabetes?
Are You a Good Fit for This Trial?
This trial is for non-smoking adults aged 50-80 with type 2 diabetes, particularly those who are sedentary. Women must be postmenopausal for over a year. It's not suitable for individuals with kidney or liver diseases, uncontrolled high blood pressure or cholesterol levels, or a history of cancer, heart disease, or stroke.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo aerobic exercise training to assess its efficacy on EPC dysfunction in T2DM
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Aerobic Exercise Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Baltimore VA Medical Center
Lead Sponsor
University of Maryland, Baltimore
Collaborator